This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
hepatitis virus | 1611 |
mouse hepatitis | 1444 |
infected cells | 667 |
murine coronavirus | 552 |
rna synthesis | 473 |
viral rna | 427 |
mhv infection | 409 |
infected mice | 346 |
virus infection | 345 |
nervous system | 311 |
central nervous | 292 |
murine hepatitis | 269 |
virus replication | 266 |
amino acid | 265 |
viral replication | 257 |
spinal cord | 247 |
genomic rna | 239 |
type i | 237 |
respiratory syndrome | 234 |
mice infected | 233 |
virus strain | 233 |
rna polymerase | 229 |
mhv strains | 227 |
gene expression | 220 |
spike protein | 219 |
viral infection | 211 |
acute respiratory | 211 |
infectious bronchitis | 210 |
severe acute | 210 |
immune response | 208 |
bronchitis virus | 200 |
rna viruses | 191 |
rna replication | 190 |
nucleocapsid protein | 189 |
strand rna | 181 |
di rna | 179 |
cell fusion | 178 |
dbt cells | 174 |
class i | 171 |
alb ts | 170 |
multiple sclerosis | 166 |
amino acids | 161 |
viral antigen | 159 |
clinical signs | 158 |
previously described | 157 |
human coronavirus | 155 |
cell lines | 154 |
syndrome coronavirus | 151 |
rna recombination | 151 |
virus type | 150 |
laboratory mice | 148 |
structural proteins | 148 |
coronavirus infection | 147 |
feline infectious | 147 |
infectious virus | 144 |
cleavage site | 144 |
immune responses | 144 |
infectious peritonitis | 143 |
monoclonal antibodies | 139 |
transmissible gastroenteritis | 139 |
cell culture | 137 |
coronavirus mouse | 131 |
cell line | 129 |
recombinant viruses | 129 |
host cell | 129 |
leader rna | 128 |
coronavirus spike | 126 |
cord uid | 125 |
viral proteins | 125 |
doc id | 125 |
coronavirus replication | 124 |
demyelinating disease | 123 |
lymph nodes | 119 |
cells infected | 118 |
epithelial cells | 118 |
immunodeficient mice | 117 |
bl mice | 117 |
coronavirus rna | 116 |
persistent infection | 116 |
white matter | 116 |
coronavirus mhv | 116 |
mhv replication | 114 |
may also | 114 |
i ifn | 113 |
open reading | 112 |
wild type | 111 |
described previously | 110 |
monoclonal antibody | 110 |
mouse strains | 109 |
rna virus | 109 |
cell surface | 109 |
mhv rna | 109 |
subgenomic mrnas | 108 |
spike glycoprotein | 106 |
mouse colonies | 106 |
stranded rna | 104 |
golgi complex | 103 |
murine coronaviruses | 103 |
viral hepatitis | 102 |
room temperature | 102 |
endoplasmic reticulum | 101 |
leader sequence | 99 |
defective interfering | 98 |
bovine coronavirus | 97 |
dependent rna | 96 |
infant mice | 96 |
mg ml | 95 |
tissue culture | 95 |
nonstructural protein | 95 |
deficient mice | 95 |
sars coronavirus | 94 |
reading frame | 93 |
sequence analysis | 93 |
immunocompetent mice | 92 |
cov nsp | 91 |
plaque assay | 90 |
plasma membrane | 89 |
vaccinia virus | 89 |
time points | 88 |
kda protein | 88 |
gastroenteritis virus | 88 |
cleavage sites | 87 |
poly i | 87 |
strain jhm | 86 |
positive cells | 86 |
clinical disease | 86 |
sars virus | 85 |
experimental infection | 84 |
coronavirus genome | 84 |
days post | 83 |
persistently infected | 83 |
electron microscopy | 83 |
spike gene | 82 |
important role | 82 |
like proteinase | 82 |
nude mice | 82 |
innate immune | 81 |
induced demyelination | 81 |
mhv spike | 81 |
virus rna | 81 |
rna species | 81 |
cell types | 80 |
rna binding | 80 |
immune system | 80 |
subgenomic mrna | 79 |
replication complex | 79 |
optic nerve | 79 |
adult mice | 79 |
endothelial cells | 79 |
intranasal inoculation | 79 |
jhm strain | 78 |
avian infectious | 78 |
membrane protein | 78 |
cell cultures | 78 |
previous studies | 76 |
terminal domain | 76 |
virus titers | 75 |
viral infections | 75 |
mhv strain | 75 |
viral titers | 74 |
suckling mice | 74 |
di rnas | 74 |
lymphocytic choriomeningitis | 73 |
ts mutants | 73 |
packaging signal | 72 |
sjl mice | 72 |
glial cells | 71 |
respiratory tract | 71 |
mice may | 71 |
infected cell | 71 |
cell monolayers | 71 |
viral envelope | 70 |
wt mice | 70 |
post infection | 69 |
closely related | 69 |
virus evolution | 69 |
virus particles | 68 |
golgi network | 68 |
viral genome | 67 |
jhm infection | 67 |
reverse genetics | 66 |
golgi apparatus | 66 |
highly conserved | 65 |
nonstructural proteins | 64 |
bone marrow | 64 |
mhv receptor | 64 |
scid mice | 63 |
determine whether | 63 |
molecular biology | 63 |
rna transcription | 63 |
binding domain | 63 |
glycoprotein gene | 62 |
structural protein | 62 |
mrna synthesis | 62 |
nsp dc | 61 |
laboratory animal | 61 |
research council | 61 |
may occur | 61 |
interfering rna | 61 |
jhm virus | 60 |
receptor binding | 60 |
data suggest | 60 |
mouse strain | 60 |
mouse brain | 60 |
cell lysates | 60 |
secondary structure | 60 |
i i | 59 |
coronavirus infectious | 59 |
permissive temperature | 59 |
fi tness | 59 |
choriomeningitis virus | 59 |
coronavirus jhm | 59 |
virus genome | 59 |
national research | 58 |
infected animals | 58 |
ribosomal frameshifting | 58 |
molecular weight | 58 |
susceptible mice | 58 |
sensitive mutants | 58 |
dna viruses | 58 |
mm tris | 57 |
mice inoculated | 57 |
proteolytic cleavage | 57 |
mhv genome | 57 |
neurotropic coronavirus | 57 |
following mhv | 57 |
present study | 57 |
three times | 57 |
rl mice | 57 |
mrna transcription | 56 |
replicase gene | 56 |
dendritic cells | 56 |
chain reaction | 56 |
pp ab | 56 |
genome replication | 56 |
peritonitis virus | 55 |
herpes simplex | 55 |
inbred strains | 55 |
polymerase gene | 55 |
time point | 55 |
human coronaviruses | 55 |
carcinoembryonic antigen | 55 |
influenza virus | 55 |
polymerase chain | 54 |
recent studies | 54 |
mononuclear cells | 54 |
targeted rna | 54 |
naturally occurring | 54 |
i expression | 54 |
bovine serum | 54 |
research complications | 53 |
ts icv | 53 |
coding region | 53 |
envelope protein | 53 |
lr cells | 52 |
polymerase activity | 52 |
biological materials | 52 |
acute infection | 52 |
recombinant mhv | 51 |
gel electrophoresis | 51 |
i interferon | 51 |
virus strains | 51 |
hepatitis viruses | 51 |
lactate dehydrogenase | 51 |
life cycle | 51 |
coronavirus nonstructural | 51 |
acid sequence | 50 |
cellular proteins | 50 |
results suggest | 50 |
virus infections | 50 |
protein synthesis | 50 |
axonal loss | 50 |
coronavirus nsp | 50 |
two different | 49 |
rna genome | 49 |
specific cd | 49 |
simplex virus | 49 |
viral antigens | 49 |
gene products | 49 |
like protease | 48 |
primary structure | 48 |
sendai virus | 48 |
proteolytic processing | 48 |
mhc class | 48 |
nucleotide sequence | 47 |
vesicular stomatitis | 47 |
optic neuritis | 47 |
brain stem | 47 |
axonal transport | 47 |
fusion protein | 47 |
natural infection | 46 |
cell responses | 46 |
untranslated region | 46 |
virus assembly | 46 |
two viruses | 46 |
procoagulant activity | 45 |
foxn nu | 45 |
adoptive transfer | 45 |
coronavirus transcription | 45 |
helper virus | 45 |
wt mhv | 45 |
coronavirus defective | 45 |
elevating virus | 45 |
type mhv | 45 |
replicase proteins | 45 |
membrane fusion | 45 |
animal medicine | 45 |
membrane vesicles | 45 |
culture medium | 44 |
mutant viruses | 44 |
crystal structure | 44 |
mhv nsp | 44 |
coronavirus nucleocapsid | 44 |
gastroenteritis coronavirus | 44 |
wild mice | 44 |
coronavirus replicase | 44 |
western blot | 44 |
viral particles | 44 |
spinal cords | 43 |
host range | 43 |
balb mice | 43 |
cell type | 43 |
ps rna | 43 |
gap junction | 43 |
coronavirus infections | 43 |
days postinfection | 43 |
encephalomyelitis virus | 43 |
targeted recombination | 42 |
binding activity | 42 |
stomatitis virus | 42 |
experimentally infected | 42 |
differential diagnosis | 42 |
demyelination induced | 42 |
performed using | 42 |
laboratory mouse | 42 |
nucleic acid | 42 |
avian coronavirus | 42 |
also observed | 42 |
pfu cell | 42 |
binding site | 42 |
viral persistence | 42 |
discontinuous transcription | 42 |
nasal mucosa | 41 |
enterotropic mhv | 41 |
biomedical research | 41 |
chronic infection | 41 |
target cells | 41 |
olfactory bulb | 41 |
animal models | 41 |
neonatal mice | 41 |
results indicate | 41 |
coronavirus gene | 41 |
secretory proteins | 41 |
buffered saline | 41 |
high levels | 41 |
following infection | 41 |
electron microscopic | 41 |
viral protein | 41 |
pca response | 41 |
viral clearance | 40 |
subgenomic rnas | 40 |
acute disease | 40 |
athymic mice | 40 |
mice develop | 40 |
strand rnas | 40 |
protein interactions | 40 |
calf serum | 40 |
total rna | 40 |
fusion activity | 40 |
fgl expression | 40 |
neutralizing antibodies | 40 |
gene encoding | 40 |
viral spread | 40 |
acute phase | 40 |
syncytia formation | 40 |
att cells | 40 |
strand synthesis | 39 |
binding protein | 39 |
antiviral activity | 39 |
even though | 39 |
following intranasal | 39 |
cell clones | 39 |
membrane proteins | 39 |
mm edta | 39 |
different strains | 39 |
group ii | 39 |
unpublished data | 39 |
optic nerves | 39 |
host cells | 39 |
hypervariable region | 39 |
rich motif | 39 |
protein expression | 38 |
fatty acid | 38 |
lethal infection | 38 |
gene polyprotein | 38 |
may develop | 38 |
studies using | 38 |
hr postinfection | 38 |
acid residues | 38 |
natural infections | 38 |
nsp nsp | 38 |
adaptive immune | 38 |
conformational changes | 38 |
also found | 38 |
replication complexes | 38 |
mesenteric lymph | 38 |
high frequency | 38 |
reverse transcriptase | 37 |
mus musculus | 37 |
immunosorbent assay | 37 |
infection may | 37 |
ifn response | 37 |
cells may | 37 |
prkdc scid | 37 |
small intestine | 37 |
intracranial inoculation | 37 |
cell tropism | 37 |
directed mutagenesis | 37 |
cdna clones | 37 |
van der | 37 |
lymph node | 37 |
reading frames | 37 |
cl cells | 37 |
bhk cells | 37 |
dna polymerase | 37 |
nlrp inflammasome | 37 |
bnip gene | 36 |
linked immunosorbent | 36 |
rna genomes | 36 |
high mortality | 36 |
immunodeficiency virus | 36 |
cytokine production | 36 |
sense rna | 36 |
viral rnas | 36 |
conserved among | 36 |
inflammatory cells | 36 |
viral nucleocapsid | 36 |
minute virus | 36 |
embryo transfer | 36 |
recombinant virus | 36 |
spike proteins | 36 |
three different | 36 |
virus binding | 35 |
resistant mice | 35 |
protein binding | 35 |
glial cell | 35 |
well plates | 35 |
lymphoid tissue | 35 |
protein genes | 35 |
sindbis virus | 35 |
acid substitutions | 35 |
cc protein | 35 |
immune cells | 35 |
mouse model | 35 |
hepatitis coronavirus | 35 |
transplanted animals | 35 |
host mrna | 35 |
pl pro | 35 |
envelope proteins | 35 |
specific rna | 35 |
cells expressing | 35 |
major histocompatibility | 34 |
virus titer | 34 |
mhv infections | 34 |
nsp mutant | 34 |
enteric coronavirus | 34 |
dengue virus | 34 |
gastrointestinal tract | 34 |
post inoculation | 34 |
laboratory rodents | 34 |
kindly provided | 34 |
jhm infected | 34 |
ectromelia virus | 34 |
liver injury | 34 |
host defense | 34 |
feline coronavirus | 34 |
rna sequence | 34 |
inflammatory response | 34 |
virus persistence | 33 |
type infection | 33 |
membrane association | 33 |
subgenomic rna | 33 |
mg kg | 33 |
dependent enhancement | 33 |
secretory pathway | 33 |
specific antibody | 33 |
critical role | 33 |
gene product | 33 |
small rnas | 33 |
low levels | 33 |
virion assembly | 33 |
leukemia virus | 33 |
pcr products | 33 |
fulminant hepatitis | 33 |
neutralizing antibody | 33 |
grey matter | 33 |
intracellular rna | 33 |
virus infectivity | 33 |
transmembrane domain | 33 |
plaque formation | 32 |
edim virus | 32 |
see section | 32 |
antiviral effect | 32 |
chronic demyelination | 32 |
old mice | 32 |
virus production | 32 |
coronavirus ibv | 32 |
genetic analysis | 32 |
like particles | 32 |
terminal half | 32 |
cleavage products | 32 |
treated mice | 32 |
cells within | 32 |
histocompatibility complex | 32 |
viral entry | 32 |
dlsse rna | 32 |
active site | 32 |
may contribute | 31 |
conformational change | 31 |
recombinant vaccinia | 31 |
chronic disease | 31 |
uninfected cells | 31 |
nu mice | 31 |
intracerebral inoculation | 31 |
virus may | 31 |
i ifns | 31 |
viral glycoprotein | 31 |
gross lesions | 31 |
susceptible strains | 31 |
protein nsp | 31 |
cleavage signal | 31 |
liver fah | 31 |
linked glycosylation | 31 |
fetal bovine | 31 |
cultured cells | 31 |
das sarma | 31 |
necrosis factor | 31 |
infected mouse | 31 |
respiratory coronavirus | 30 |
mouse liver | 30 |
induced demyelinating | 30 |
sialic acid | 30 |
control mice | 30 |
cell response | 30 |
acute encephalitis | 30 |
virus entry | 30 |
weanling mice | 30 |
polyacrylamide gel | 30 |
upper respiratory | 30 |
salivary glands | 30 |
newly synthesized | 30 |
takes place | 30 |
nucleoside analogues | 30 |
nsp mutants | 30 |
mice following | 30 |
genome rna | 29 |
human immunodeficiency | 29 |
pfu ml | 29 |
rabbit anti | 29 |
natural host | 29 |
medium containing | 29 |
middle east | 29 |
carboxy terminus | 29 |
direct contact | 29 |
tm domain | 29 |
ribosome profiling | 29 |
animal model | 29 |
balb cj | 29 |
meningeal fibroblasts | 29 |
newborn mice | 29 |
axonal damage | 29 |
infected macrophages | 29 |
zinc finger | 29 |
reporter gene | 29 |
mice lacking | 29 |
human respiratory | 29 |
mouse parvovirus | 29 |
coronavirus oc | 29 |
mrna species | 29 |
mrna levels | 29 |
washed three | 29 |
ea fraction | 29 |
mouse cells | 29 |
enveloped viruses | 29 |
intracellular membranes | 29 |
permeabilized cells | 28 |
murine cells | 28 |
total number | 28 |
escherichia coli | 28 |
cervical lymph | 28 |
svev mice | 28 |
mutant virus | 28 |
expression levels | 28 |
nk cells | 28 |
antigenic relationships | 28 |
significant differences | 28 |
ng ml | 28 |
infl uenza | 28 |
plasmid dna | 28 |
may cause | 28 |
strain mhv | 28 |
present within | 28 |
recombination frequency | 28 |
interfering rnas | 28 |
significantly higher | 28 |
point mutations | 28 |
type virus | 28 |
complementation groups | 28 |
transcriptase complex | 28 |
natural killer | 28 |
demyelinating diseases | 28 |
goat anti | 28 |
determined using | 28 |
may provide | 28 |
current study | 28 |
agarose gel | 28 |
may play | 28 |
recombinant mouse | 27 |
murine leukemia | 27 |
nsp protein | 27 |
different cell | 27 |
translation products | 27 |
mm nacl | 27 |
reticulocyte lysate | 27 |
weight loss | 27 |
protein gene | 27 |
statistically significant | 27 |
situ hybridization | 27 |
rna sequences | 27 |
mouse populations | 27 |
east respiratory | 27 |
like receptor | 27 |
significantly different | 27 |
acting elements | 27 |
like proteases | 27 |
pneumonia virus | 27 |
stem cells | 27 |
nested set | 26 |
terminal region | 26 |
cell activation | 26 |
mouse igg | 26 |
infectious cdna | 26 |
fetal calf | 26 |
murine encephalomyelitis | 26 |
virion rna | 26 |
specific interaction | 26 |
autoimmune encephalomyelitis | 26 |
family coronaviridae | 26 |
specific antibodies | 26 |
demyelinating encephalomyelitis | 26 |
infectious diseases | 26 |
mice also | 26 |
experimental autoimmune | 26 |
inbred strain | 26 |
blot analysis | 26 |
pg ml | 26 |
hela cells | 26 |
rna structure | 26 |
acid sequences | 26 |
serological tests | 26 |
athymic nude | 26 |
hej mice | 26 |
viral fh | 26 |
active infection | 26 |
intracellular transport | 26 |
laboratory animals | 26 |
equine arteritis | 26 |
treated cells | 26 |
protein may | 26 |
forming units | 26 |
liver disease | 26 |
may result | 26 |
virus isolation | 26 |
united states | 25 |
national institutes | 25 |
arteritis virus | 25 |
commonly used | 25 |
surface glycoprotein | 25 |
highly susceptible | 25 |
reovirus infection | 25 |
immune complex | 25 |
nitric oxide | 25 |
taken together | 25 |
viral infectivity | 25 |
viral genomic | 25 |
like protein | 25 |
least one | 25 |
cs recombinants | 25 |
antibody response | 25 |
hepatic necrosis | 25 |
virus spread | 25 |
coronavirus mrnas | 25 |
experimental inoculation | 25 |
humoral immune | 25 |
murine norovirus | 25 |
demyelinating strain | 25 |
spleen cells | 25 |
aa substitutions | 25 |
mice showed | 25 |
washed twice | 25 |
differential expression | 25 |
virus infected | 25 |
host factors | 25 |
consensus sequence | 25 |
virology doi | 25 |
pbs containing | 25 |
peripheral blood | 25 |
naturally infected | 25 |
viral mrnas | 25 |
binding sites | 25 |
murine virus | 25 |
similar results | 25 |
genetic background | 25 |
indirect immunofluorescence | 25 |
pcr assays | 25 |
cytopathic effects | 25 |
functional domains | 25 |
rna elements | 25 |
proteins involved | 25 |
rat liver | 25 |
infectious agents | 25 |
porcine respiratory | 24 |
see chapter | 24 |
mouse models | 24 |
ri strains | 24 |
rna pseudoknot | 24 |
mhv di | 24 |
class ii | 24 |
electron microscope | 24 |
least two | 24 |
data indicate | 24 |
peritoneal macrophages | 24 |
fold change | 24 |
system disease | 24 |
mtase activity | 24 |
subgenomic negative | 24 |
flow cytometry | 24 |
complementation group | 24 |
major determinant | 24 |
induced cell | 24 |
coronavirus mrna | 24 |
brain barrier | 24 |
virus inoculation | 24 |
viral replicase | 24 |
recent study | 24 |
exon activity | 24 |
genetic resistance | 24 |
brain cells | 24 |
genetically susceptible | 24 |
novel coronavirus | 24 |
vitro translation | 24 |
two distinct | 24 |
luciferase activity | 24 |
cysteine proteinase | 24 |
much higher | 24 |
porcine transmissible | 24 |
cells using | 24 |
acute hepatitis | 24 |
highly contagious | 24 |
results show | 24 |
technical assistance | 24 |
tumor necrosis | 24 |
mouse serum | 24 |
virus adsorption | 24 |
san diego | 24 |
recombination events | 23 |
knockout mice | 23 |
structural elements | 23 |
envelope glycoprotein | 23 |
luciferase expression | 23 |
major role | 23 |
generated using | 23 |
different mhv | 23 |
reovirus type | 23 |
genome regions | 23 |
results demonstrate | 23 |
large number | 23 |
balb cbyj | 23 |
mouse cell | 23 |
previously reported | 23 |
murine cytomegalovirus | 23 |
coronavirus envelope | 23 |
mediated demyelination | 23 |
nucleic acids | 23 |
integral membrane | 23 |
liver damage | 23 |
inbred mice | 23 |
three viruses | 23 |
acting rna | 23 |
syncytium formation | 23 |
health surveillance | 23 |
induce demyelination | 23 |
deletion mutant | 23 |
tissue tropism | 23 |
complete sequence | 23 |
host evolution | 23 |
protein products | 23 |
young mice | 23 |
viruses may | 23 |
per ml | 23 |
chronic demyelinating | 23 |
polyacrylamide gels | 23 |
contains two | 23 |
independent experiments | 23 |
terminal amino | 23 |
nucleoside analogue | 23 |
viral pathogenesis | 23 |
analysis using | 23 |
relationships among | 23 |
peplomer protein | 22 |
chronic hepatitis | 22 |
canine coronavirus | 22 |
significantly reduced | 22 |
disease virus | 22 |
lewis rats | 22 |
cells transfected | 22 |
intestinal tract | 22 |
viral mrna | 22 |
antigenically related | 22 |
fluorescent protein | 22 |
results obtained | 22 |
also detected | 22 |
meningeal cells | 22 |
protein complex | 22 |
respiratory syncytial | 22 |
essential medium | 22 |
peplomer glycoprotein | 22 |
type ii | 22 |
cov replication | 22 |
time pcr | 22 |
cellular receptor | 22 |
fcwf cells | 22 |
rna levels | 22 |
protein complexes | 22 |
experimental demyelination | 22 |
embryonic stem | 22 |
day post | 22 |
mice treated | 22 |
liver tissue | 22 |
negative strands | 22 |
per se | 22 |
neurotropic mhv | 22 |
vitro transcription | 22 |
encephalitis virus | 22 |
neurological disease | 22 |
sensitive mutant | 22 |
antigen expression | 22 |
results showed | 22 |
coding sequence | 21 |
cell receptor | 21 |
gray matter | 21 |
horseradish peroxidase | 21 |
statistical analysis | 21 |
membrane glycoprotein | 21 |
demyelination produced | 21 |
transgenic mice | 21 |
rna polymerases | 21 |
higher levels | 21 |
low virulence | 21 |
mouse adenovirus | 21 |
largest rna | 21 |
inducing activity | 21 |
group coronaviruses | 21 |
coronavirus strain | 21 |
viral growth | 21 |
infection induces | 21 |
antigen family | 21 |
antiviral effects | 21 |
expression level | 21 |
proteinase activity | 21 |
golgi compartments | 21 |
ruffled fur | 21 |
innate immunity | 21 |
complex formation | 21 |
ts mutant | 21 |
host genotype | 21 |
breeding colony | 21 |
log reduction | 21 |
mouse thymic | 21 |
antibody production | 21 |
nsp proteins | 21 |
coronavirus particles | 21 |
macrophages microglia | 21 |
mhv genomic | 21 |
nucleocapsid gene | 21 |
lymphoid tissues | 21 |
two groups | 21 |
binding proteins | 21 |
target cell | 21 |
like cysteine | 21 |
replication cycle | 21 |
viral fusion | 21 |
may reflect | 21 |
rough endoplasmic | 21 |
applied biosystems | 21 |
exocytic pathway | 21 |
hk protein | 21 |
infected colonies | 21 |
cov infection | 21 |
structural polypeptides | 21 |
site mutations | 21 |
cns disease | 21 |
lcmv infection | 21 |
coronavirus avian | 21 |
dc cells | 21 |
two orfs | 21 |
also shown | 21 |
polymerase polyprotein | 21 |
molecular cloning | 20 |
green fluorescent | 20 |
protein kinase | 20 |
myelin sheath | 20 |
buffer containing | 20 |
apoptotic cells | 20 |
transfected cells | 20 |
genome sequence | 20 |
fibrinogen deposition | 20 |
four proteins | 20 |
membrane topology | 20 |
cell populations | 20 |
transplantable tumours | 20 |
survival rate | 20 |
cj mice | 20 |
red blood | 20 |
pcr product | 20 |
different coronaviruses | 20 |
first detected | 20 |
severe disease | 20 |
virus jhm | 20 |
also known | 20 |
secretory granules | 20 |
different viruses | 20 |
efficient ribosomal | 20 |
helicobacter spp | 20 |
reverse transcription | 20 |
cell membrane | 20 |
temperature sensitive | 20 |
within days | 20 |
type culture | 20 |
experimental allergic | 20 |
host immune | 20 |
data obtained | 20 |
cellular membranes | 20 |
also may | 20 |
chronically infected | 20 |
demyelinating lesions | 20 |
sclerosis patients | 20 |
resident microglia | 20 |
specific binding | 20 |
pol zn | 20 |
culture collection | 20 |
also possible | 20 |
experimental conditions | 20 |
vero cells | 20 |
experimental infections | 20 |
neuronal infection | 20 |
stop codon | 20 |
cns resident | 20 |
cytoplasmic tail | 20 |
organ tropism | 20 |
health care | 20 |
genome organization | 20 |
secondary structures | 20 |
mouse colony | 20 |
persistent infections | 20 |
susceptible cells | 20 |
rna structures | 20 |
chimeric spike | 20 |
body weight | 19 |
syncytial virus | 19 |
protein expressed | 19 |
affected mice | 19 |
leader sequences | 19 |
extensive destruction | 19 |
biochemical characterization | 19 |
viral titer | 19 |
cytopathic effect | 19 |
progeny virions | 19 |
mouse coronavirus | 19 |
infected cultures | 19 |
replicase products | 19 |
molecular mechanisms | 19 |
immune complexes | 19 |
dba mice | 19 |
heterogeneous nuclear | 19 |
rna packaging | 19 |
virus nucleocapsid | 19 |
respiratory viruses | 19 |
causing disseminated | 19 |
cdna synthesis | 19 |
immunocompromised mice | 19 |
mhv virions | 19 |
animal species | 19 |
breeding colonies | 19 |
polyamine depletion | 19 |
acid substitution | 19 |
mhvr cells | 19 |
thymic virus | 19 |
least three | 19 |
protein binds | 19 |
microscopic studies | 19 |
sample buffer | 19 |
transcription factor | 19 |
viral load | 19 |
cd cd | 19 |
line dbt | 19 |
molecular basis | 19 |
respiratory disease | 19 |
older mice | 19 |
amino terminus | 19 |
within nsp | 19 |
rna secondary | 19 |
chemokine receptor | 19 |
studies suggest | 19 |
american type | 19 |
purified virions | 19 |
mrna start | 19 |
order nidovirales | 19 |
induced disease | 19 |
cord white | 19 |
helicobacter hepaticus | 19 |
fisher scientific | 19 |
control group | 19 |
charged residues | 19 |
semliki forest | 19 |
viral structural | 19 |
differentially expressed | 19 |
disulfide bonds | 19 |
model system | 19 |
signaling pathway | 19 |
surface projections | 19 |
days later | 19 |
terminal part | 19 |
infected dbt | 19 |
inclusion bodies | 19 |
previous reports | 18 |
units ml | 18 |
vitro models | 18 |
west nile | 18 |
nasal cavity | 18 |
condensing secretory | 18 |
mycoplasmal infections | 18 |
condensed secretory | 18 |
replication fidelity | 18 |
family members | 18 |
mhv polymerase | 18 |
mhv antigen | 18 |
signal sequence | 18 |
infant mouse | 18 |
cc chemokine | 18 |
serological testing | 18 |
expression system | 18 |
host interactions | 18 |
coronavirus assembly | 18 |
among different | 18 |
infected samples | 18 |
antibody responses | 18 |
membrane structures | 18 |
two strains | 18 |
proteins may | 18 |
deletion mutants | 18 |
neural cell | 18 |
positively charged | 18 |
independent fusion | 18 |
coronavirus strains | 18 |
measles virus | 18 |
passive immunity | 18 |
growth factor | 18 |
previously shown | 18 |
dependent manner | 18 |
hemorrhagic fever | 18 |
distantly related | 18 |
histopathological changes | 18 |
fusion phenotype | 18 |
liver tissues | 18 |
susceptible animals | 18 |
containing mm | 18 |
disseminated encephalomyelitis | 18 |
es cells | 18 |
length infectious | 18 |
coronavirus leader | 18 |
first days | 18 |
virus growth | 18 |
table i | 18 |
see later | 18 |
nude mouse | 18 |
contemporary mouse | 18 |
nsp complex | 18 |
extended host | 18 |
lysis buffer | 18 |
mouse spinal | 18 |
plaque assays | 18 |
viruses containing | 18 |
cdna clone | 18 |
golgi cisternae | 18 |
mrna expression | 18 |
final concentration | 18 |
large rna | 18 |
virus expressing | 18 |
transcription factors | 18 |
lymphoid organs | 18 |
bhk mceacam | 18 |
heparan sulfate | 18 |
i molecules | 18 |
cl cell | 18 |
forest virus | 18 |
cell membranes | 18 |
blood cells | 18 |
may represent | 18 |
coronavirus genomes | 17 |
one day | 17 |
murid herpesvirus | 17 |
may affect | 17 |
allergic encephalomyelitis | 17 |
three strains | 17 |
recognition receptors | 17 |
experimental evidence | 17 |
experimentally induced | 17 |
previously demonstrated | 17 |
infected rl | 17 |
take place | 17 |
following viral | 17 |
protect mice | 17 |
reverse genetic | 17 |
genetically modified | 17 |
molecular weights | 17 |
dna replication | 17 |
disease severity | 17 |
fi delity | 17 |
protease activity | 17 |
rna mutants | 17 |
low prevalence | 17 |
mhv mutants | 17 |
genetics system | 17 |
viral glycoproteins | 17 |
immune dams | 17 |
well understood | 17 |
per cell | 17 |
ccl signaling | 17 |
type mice | 17 |
dna virus | 17 |
fulminant viral | 17 |
primary antibodies | 17 |
mediated immunity | 17 |
analysis revealed | 17 |
significant difference | 17 |
several different | 17 |
following i | 17 |
potential role | 17 |
protective effect | 17 |
early stage | 17 |
mouse embryonic | 17 |
nile virus | 17 |
axonal degeneration | 17 |
cell adhesion | 17 |
three independent | 17 |
mutations within | 17 |
fatal central | 17 |
infectious disease | 17 |
also showed | 17 |
initiation site | 17 |
nuclear ribonucleoprotein | 17 |
incubation period | 17 |
die within | 17 |
secondary antibody | 17 |
chemokine receptors | 17 |
infections may | 17 |
ms patients | 17 |
cytoplasmic rna | 17 |
using recombinant | 17 |
salivary gland | 17 |
rabbit reticulocyte | 17 |
mutational analysis | 17 |
primary meningeal | 17 |
female mice | 17 |
strains tested | 17 |
like structures | 17 |
cell entry | 17 |
genetically engineered | 17 |
terminal sequence | 17 |
genome expression | 17 |
terminal genome | 17 |
insect cells | 17 |
tract disease | 17 |
berne virus | 17 |
environmental conditions | 17 |
heb fej | 17 |
infected glial | 17 |
dbt cell | 17 |
western blotting | 17 |
sentinel mice | 17 |
cysteine residues | 17 |
inbred mouse | 17 |
gene networks | 17 |
life technologies | 17 |
structural basis | 17 |
infection also | 17 |
acute stage | 17 |
neutralizing epitopes | 17 |
envelope glycoproteins | 17 |
magnetic resonance | 17 |
immediately downstream | 17 |
different virus | 17 |
feline enteric | 17 |
transplantable tumors | 17 |
biological properties | 17 |
mouse genome | 17 |
unpublished results | 17 |
rna structural | 17 |
tissue damage | 17 |
acute encephalomyelitis | 17 |
hepatic injury | 17 |
future studies | 16 |
cells via | 16 |
sodium dodecyl | 16 |
cell proliferation | 16 |
also present | 16 |
replicase polyprotein | 16 |
highly neurovirulent | 16 |
presenting cells | 16 |
mhv proteins | 16 |
dc virus | 16 |
several studies | 16 |
virus gene | 16 |
may involve | 16 |
histological lesions | 16 |
induced expression | 16 |
maternal immunity | 16 |
oas rnase | 16 |
rsa infection | 16 |
nk cell | 16 |
transmembrane domains | 16 |
pathogenic murine | 16 |
essential role | 16 |
cell death | 16 |
stranded dna | 16 |
also important | 16 |
sarcoma virus | 16 |
proteinase domain | 16 |
various times | 16 |
adhesion molecule | 16 |
microarray analysis | 16 |
rna recombinant | 16 |
associated coronavirus | 16 |
necrotic foci | 16 |
also used | 16 |
viral receptor | 16 |
adherent cells | 16 |
vertical transmission | 16 |
neurotropic murine | 16 |
nonpermissive temperature | 16 |
like receptors | 16 |
mechanisms underlying | 16 |
ga treatment | 16 |
cell lysis | 16 |
double membrane | 16 |
sequence homology | 16 |
golgi vesicles | 16 |
monocyte procoagulant | 16 |
inhibitory effect | 16 |
free leader | 16 |
cells treated | 16 |
much less | 16 |
ccl mice | 16 |
may lead | 16 |
cns demyelination | 16 |
hunched posture | 16 |
two independent | 16 |
specific infectivity | 16 |
revertant viruses | 16 |
molecular mechanism | 16 |
intermediate compartment | 16 |
cell infiltration | 16 |
male mice | 16 |
minimal essential | 16 |
protein cleavage | 16 |
strain infection | 16 |
serum albumin | 16 |
mice results | 16 |
proteins encoded | 16 |
golgi membranes | 16 |
virus dissemination | 16 |
helical nucleocapsids | 16 |
cellular rna | 16 |
coronavirus replicative | 16 |
vector laboratories | 16 |
neutralization tests | 16 |
brain sections | 16 |
mutant hnrnp | 16 |
replicase protein | 16 |
public health | 16 |
host resistance | 16 |
cellular immunity | 16 |
cient mice | 16 |
murine viruses | 16 |
protein processing | 16 |
cap structure | 16 |
mortality rates | 16 |
containing rna | 16 |
may contain | 16 |
cytomegalovirus infection | 16 |
sequence identity | 16 |
chronic viral | 16 |
induced fh | 16 |
restriction enzyme | 16 |
inflammatory cytokines | 16 |
mm hepes | 16 |
epithelial cell | 16 |
mycoplasma pulmonis | 16 |
viral membrane | 16 |
secondary antibodies | 16 |
murine models | 16 |
close proximity | 16 |
frameshifting mechanism | 16 |
virus budding | 16 |
mammalian cells | 16 |
length distributions | 16 |
serial dilutions | 16 |
data show | 16 |
genome structure | 16 |
two separate | 16 |
cell population | 16 |
inoculated mice | 16 |
significantly increased | 16 |
virus nonstructural | 16 |
two additional | 16 |
time course | 15 |
ig sequences | 15 |
poorly understood | 15 |
infection occurs | 15 |
terminal residues | 15 |
rsmhv egfp | 15 |
inoculated intranasally | 15 |
two subunits | 15 |
age groups | 15 |
autoimmune response | 15 |
houttuynia cordata | 15 |
barrier maintenance | 15 |
effector function | 15 |
enhanced green | 15 |
plaque forming | 15 |
ii coronaviruses | 15 |
ctl clone | 15 |
several strains | 15 |
mhv infected | 15 |
nsp dmid | 15 |
acute mhv | 15 |
fusion conformation | 15 |
nondenaturing gel | 15 |
experimental procedures | 15 |
large numbers | 15 |
rhesus macaques | 15 |
group i | 15 |
caesarean derivation | 15 |
map test | 15 |
neutral red | 15 |
golgi compartment | 15 |
immune status | 15 |
skin lesions | 15 |
infectious clone | 15 |
pneumocystis carinii | 15 |
persistent viral | 15 |
deficient coronaviruses | 15 |
personal communication | 15 |
virus replicase | 15 |
helical nucleocapsid | 15 |
termination codon | 15 |
immunologically mediated | 15 |
jackson laboratory | 15 |
serum antibodies | 15 |
disease susceptibility | 15 |
culture cells | 15 |
quantitative rt | 15 |
evolutionary biology | 15 |
negative strand | 15 |
among mhv | 15 |
results suggested | 15 |
swiss mice | 15 |
viruses formed | 15 |
low level | 15 |
specific igg | 15 |
widely used | 15 |
genes involved | 15 |
antibody complexes | 15 |
coronavirus subgenomic | 15 |
mutant mouse | 15 |
dirty bedding | 15 |
firefly luciferase | 15 |
following intracranial | 15 |
enterotropic strains | 15 |
virulent mhv | 15 |
virion envelope | 15 |
genetic variation | 15 |
sequence comparison | 15 |
ibv spike | 15 |
virus nsp | 15 |
myelin loss | 15 |
rat anti | 15 |
enteric coronaviruses | 15 |
molecular mimicry | 15 |
cell suspensions | 15 |
disease induced | 15 |
organ culture | 15 |
site within | 15 |
cerebrospinal fluid | 15 |
growth kinetics | 15 |
lg ml | 15 |
deficient macrophages | 15 |
findings suggest | 15 |
cellular factors | 15 |
epidemic diarrhea | 15 |
transition mutations | 15 |
mice exhibited | 15 |
allowed us | 15 |
brain homogenates | 15 |
neurological signs | 15 |
cruzi infection | 15 |
gene co | 15 |
biliary glycoprotein | 15 |
north america | 15 |
increased replication | 15 |
oc infection | 15 |
several weeks | 15 |
ethidium bromide | 15 |
cells per | 15 |
using primers | 15 |
infected ccl | 15 |
earlier studies | 15 |
hair coat | 15 |
system demyelination | 15 |
wide variety | 15 |
calculated using | 15 |
chronic central | 15 |
putative polymerase | 15 |
coronavirus family | 15 |
studies showed | 15 |
dodecyl sulfate | 15 |
helicobacter species | 15 |
rsa egfp | 15 |
serum antibody | 15 |
major site | 15 |
diarrhea virus | 15 |
relatively resistant | 15 |
data presented | 15 |
rna molecules | 15 |
genetic control | 15 |
virus shedding | 15 |
intranasal administration | 15 |
infected astrocytes | 15 |
equal volume | 15 |
unpublished observations | 15 |
dmem containing | 15 |
prior studies | 15 |
enveloped rna | 15 |
enzymatic activities | 15 |
virus recovery | 15 |
bacterial infections | 15 |
nucleotide sequences | 15 |
cause severe | 15 |
infected tissues | 15 |
bnip promoter | 14 |
protective immunity | 14 |
new insights | 14 |
systematic assembly | 14 |
disease caused | 14 |
mice mouse | 14 |
restrictive temperature | 14 |
mice experimentally | 14 |
mouse fah | 14 |
several days | 14 |
rna intermediates | 14 |
hydrophobic domain | 14 |
putative rna | 14 |
also thank | 14 |
functional role | 14 |
two large | 14 |
like virus | 14 |
eukaryotic dna | 14 |
later time | 14 |
resistant sjl | 14 |
strand templates | 14 |
increased mortality | 14 |
rna template | 14 |
early secretory | 14 |
clostridium difficile | 14 |
induced fusion | 14 |
liver failure | 14 |
homologous recombination | 14 |
mhv pseudoviruses | 14 |
small plaque | 14 |
efficient replication | 14 |
nhc inhibition | 14 |
intraperitoneal inoculation | 14 |
delayed fusion | 14 |
macrophage activation | 14 |
bnip expression | 14 |
motif i | 14 |
severe combined | 14 |
yet clear | 14 |
immune mediated | 14 |
gamma interferon | 14 |
sequence conservation | 14 |
host gene | 14 |
accessory proteins | 14 |
protein sequence | 14 |
intranuclear inclusions | 14 |
coronavirus associated | 14 |
specific rnas | 14 |
large dna | 14 |
recombinant mbp | 14 |
guinea pigs | 14 |
encoded proteinases | 14 |
mhv may | 14 |
fusion peptide | 14 |
animals treated | 14 |
mock infected | 14 |
maternal antibody | 14 |
infected intranasally | 14 |
mice developed | 14 |
results indicated | 14 |
defective mutants | 14 |
neurologic disease | 14 |
effector functions | 14 |
natural conditions | 14 |
rna may | 14 |
cbyj mice | 14 |
intestinal mucosa | 14 |
microglia macrophages | 14 |
one set | 14 |
sequence motifs | 14 |
related genes | 14 |
relatively low | 14 |
recombination frequencies | 14 |
international committee | 14 |
trypanosoma cruzi | 14 |
trizol reagent | 14 |
embryonated eggs | 14 |
virus specific | 14 |
products spanning | 14 |
fej mice | 14 |
virus envelope | 14 |
comparative analysis | 14 |
mhv clpro | 14 |
induced cns | 14 |
soluble receptor | 14 |
point mutation | 14 |
signal peptide | 14 |
previous study | 14 |
virus mhv | 14 |
mhv model | 14 |
early stages | 14 |
contained within | 14 |
genomic sequence | 14 |
ependymal cells | 14 |
surviving mice | 14 |
shown previously | 14 |
negative control | 14 |
bowel disease | 14 |
sequence similarity | 14 |
inflammatory cell | 14 |
coronavirus group | 14 |
fever virus | 14 |
blood vessels | 14 |
additional file | 14 |
retrograde axonal | 14 |
obtained using | 14 |
nadph oxidase | 14 |
enzootically infected | 14 |
catalytic residues | 14 |
cellular immune | 14 |
accession number | 14 |
standard deviation | 14 |
plaque morphology | 14 |
low dose | 14 |
viral control | 14 |
two sets | 14 |
antigenic sites | 14 |
standard plaque | 14 |
sites within | 14 |
well plate | 14 |
biological activities | 14 |
containing rnas | 14 |
molecular mass | 14 |
th clone | 14 |
virus also | 14 |
proteolytic products | 14 |
per cent | 14 |
cns tissue | 14 |
house mice | 14 |
structure probing | 14 |
recombinants containing | 14 |
approximately kda | 14 |
acute inflammation | 14 |
small number | 14 |
demyelination determinants | 14 |
high titers | 14 |
wasting syndrome | 14 |
antiviral responses | 14 |
intracellular localization | 14 |
also occurs | 14 |
cellular receptors | 14 |
functional analysis | 14 |
acting sequences | 14 |
contact time | 14 |
using monoclonal | 14 |
host species | 14 |
hindlimb paralysis | 14 |
mouse leukemia | 14 |
short orf | 14 |
lethal mutagenesis | 14 |
susceptible balb | 14 |
strand template | 14 |
cell epitope | 14 |
nsp dfl | 14 |
inflammatory demyelination | 14 |
sg mrnas | 14 |
incubated overnight | 14 |
specific intracellular | 14 |
like proteinases | 14 |
virus stocks | 14 |
differences among | 14 |
experiments using | 14 |
human cytomegalovirus | 13 |
pathogenic properties | 13 |
aspartic acid | 13 |
i interferons | 13 |
defective viral | 13 |
single amino | 13 |
vitro transcribed | 13 |
reported previously | 13 |
infection results | 13 |
respiratory epithelial | 13 |
virus persists | 13 |
dna microarray | 13 |
protein also | 13 |
inflammasome activation | 13 |
virus particle | 13 |
two types | 13 |
rna probe | 13 |
jhm genomic | 13 |
octanucleotide sequence | 13 |
virus encephalomyelitis | 13 |
different time | 13 |
programmed death | 13 |
culture supernatant | 13 |
expression vector | 13 |
igg titers | 13 |
data suggested | 13 |
efficient coronavirus | 13 |
frequency rna | 13 |
antiviral drugs | 13 |
interfering particles | 13 |
immunofluorescence staining | 13 |
polytropic mhv | 13 |
mediated immune | 13 |
positive control | 13 |
may serve | 13 |
complement fixation | 13 |
necrotic lesions | 13 |
acid composition | 13 |
cns following | 13 |
data support | 13 |
gene ly | 13 |
gene order | 13 |
strains mhv | 13 |
significantly lower | 13 |
hairpin loops | 13 |
interstitial pneumonia | 13 |
antibody titers | 13 |
treated group | 13 |
progenitor cells | 13 |
host mrnas | 13 |
tissue homogenates | 13 |
pro cleavage | 13 |
mice exposed | 13 |
virus defective | 13 |
primary target | 13 |
inoculated intracranially | 13 |
atpase activity | 13 |
virus mouse | 13 |
quality control | 13 |
virus induced | 13 |
virus takes | 13 |
choroid plexus | 13 |
host proteins | 13 |
plaque reduction | 13 |
bfa treatment | 13 |
hydrophobic domains | 13 |
rotavirus infection | 13 |
various mhv | 13 |
disease progression | 13 |
mdck cells | 13 |
expressed genes | 13 |
inflammatory responses | 13 |
large amounts | 13 |
endou activity | 13 |
one another | 13 |
ldv infection | 13 |
early phase | 13 |
cell function | 13 |
cells incubated | 13 |
lipid bilayer | 13 |
using mhv | 13 |
acid metabolism | 13 |
nsp protease | 13 |
enterotropic mouse | 13 |
amino terminal | 13 |
base pairs | 13 |
mouse genotypes | 13 |
specific monoclonal | 13 |
similar pattern | 13 |
coronavirus membrane | 13 |
infected rag | 13 |
induced liver | 13 |
transcription initiation | 13 |
late time | 13 |
cells following | 13 |
become infected | 13 |
ribosomal pausing | 13 |
rna interactions | 13 |
data demonstrate | 13 |
studies demonstrated | 13 |
neural cells | 13 |
clear whether | 13 |
length negative | 13 |
primed transcription | 13 |
see earlier | 13 |
gene sequence | 13 |
mortality rate | 13 |
lytic infection | 13 |
viral genomes | 13 |
way anova | 13 |
see table | 13 |
recombination within | 13 |
strain dependent | 13 |
induce optic | 13 |
ucuaa repeats | 13 |
mediated clearance | 13 |
may persist | 13 |
shed virus | 13 |
mutational robustness | 13 |
cleavage product | 13 |
blood flow | 13 |
replicase complex | 13 |
end genomic | 13 |
nerve inflammation | 13 |
rna transcripts | 13 |
different types | 13 |
coterminal nested | 13 |
initiation codon | 13 |
acting signals | 13 |
high incidence | 13 |
feline coronaviruses | 13 |
immune cell | 13 |
coronavirus main | 13 |
protein levels | 13 |
lymphoid cells | 13 |
fold increase | 13 |
slippery sequence | 13 |
membrane rearrangements | 13 |
copy number | 13 |
animal care | 13 |
length distribution | 13 |
subgenomic minus | 13 |
genetically resistant | 13 |
goat serum | 13 |
mm sodium | 13 |
structural analysis | 13 |
uninfected mice | 13 |
also demonstrated | 13 |
signature genes | 13 |
fusion sites | 13 |
infected balb | 13 |
mhv antibody | 13 |
primary antibody | 13 |
neurovirulent mhv | 13 |
lamina propria | 13 |
various concentrations | 13 |
viable cells | 13 |
axonal injury | 13 |
replication kinetics | 13 |
fold dilutions | 13 |
along olfactory | 13 |
binding element | 13 |
free mice | 13 |
carrier state | 13 |
liver pathology | 13 |
among mice | 13 |
plasma cells | 13 |
high level | 13 |
like cells | 13 |
recombination sites | 13 |
specific proteins | 13 |
mhv serum | 13 |
vitro studies | 13 |
rnaseq density | 13 |
intracellular membrane | 13 |
antigenic determinants | 13 |
expression networks | 13 |
mice persistently | 13 |
secretory protein | 13 |
synthetic peptides | 13 |
ns proteins | 13 |
athymic foxn | 13 |
coronavirus packaging | 13 |
reduced viral | 13 |
murine cell | 13 |
first time | 13 |
neurological fip | 13 |
fold higher | 13 |
putative functional | 13 |
increased expression | 13 |
gene recombinants | 13 |
causative agent | 13 |
virus isolated | 13 |
genetic diversity | 12 |
oxidative stress | 12 |
detect viral | 12 |
induced neurologic | 12 |
ribosomal frameshift | 12 |
barr virus | 12 |
mhv disease | 12 |
chikungunya virus | 12 |
strongly neurotropic | 12 |
frameshifting signal | 12 |
ascites fluids | 12 |
various time | 12 |
functional characterization | 12 |
wt hnrnp | 12 |
indicated times | 12 |
recombinant ibv | 12 |
cov rna | 12 |
tumor cells | 12 |
riboseq chx | 12 |
antiviral response | 12 |
coronavirus genomic | 12 |
different viral | 12 |
neurotropic viruses | 12 |
trypsin treatment | 12 |
induced fulminant | 12 |
genetic recombination | 12 |
eliminate infection | 12 |
junction communication | 12 |
viral genes | 12 |
study showed | 12 |
foster city | 12 |
coronavirus genes | 12 |
plasmacytoid dendritic | 12 |
coronaviridae family | 12 |
recombination map | 12 |
antigenically distinct | 12 |
system requires | 12 |
associated lymphoid | 12 |
human cells | 12 |
mhv entry | 12 |
cdna probe | 12 |
day pi | 12 |
ribosomal frame | 12 |
kidney cells | 12 |
coronavirus glycoprotein | 12 |
analyzed using | 12 |
virus transcription | 12 |
like mhv | 12 |
several coronaviruses | 12 |
endogenous retroviruses | 12 |
infection resulted | 12 |
main protease | 12 |
porcine epidemic | 12 |
significant role | 12 |
coronavirus protein | 12 |
synthesized viral | 12 |
less susceptible | 12 |
mice per | 12 |
graphpad prism | 12 |
neurological diseases | 12 |
must also | 12 |
pcr using | 12 |
inhibitory effects | 12 |
plaque purification | 12 |
investigate whether | 12 |
within weeks | 12 |
golgi stack | 12 |
including mhv | 12 |
pcr analysis | 12 |
rna containing | 12 |
precipitable material | 12 |
inflammatory bowel | 12 |
functional significance | 12 |
cellular protein | 12 |
st mice | 12 |
membrane binding | 12 |
rna persistence | 12 |
adult immunocompetent | 12 |
detected within | 12 |
infected murine | 12 |
rna reveals | 12 |
control animals | 12 |
genetic factors | 12 |
tlr signaling | 12 |
tlr ligands | 12 |
replication strategy | 12 |
different mechanisms | 12 |
rdrp domain | 12 |
polymerase activities | 12 |
olfactory cortex | 12 |
carrier mice | 12 |
since mhv | 12 |
dependent differences | 12 |
observations suggest | 12 |
neurotropic strains | 12 |
autoimmune disease | 12 |
several months | 12 |
genbank accession | 12 |
ibv genome | 12 |
kind gift | 12 |
killer cells | 12 |
brain tissue | 12 |
plaque purified | 12 |
intravenous inoculation | 12 |
receptor function | 12 |
disease process | 12 |
phosphate buffer | 12 |
analysis showed | 12 |
wt vol | 12 |
also indicate | 12 |
template rna | 12 |
adaptive immunity | 12 |
growth medium | 12 |
protein translated | 12 |
pfu per | 12 |
image analysis | 12 |
telbivudine treatment | 12 |
recombinant mhvs | 12 |
glycosylation sites | 12 |
two major | 12 |
may function | 12 |
virus characterization | 12 |
coronaviruses may | 12 |
low concentrations | 12 |
polyclonal rabbit | 12 |
mm dtt | 12 |
sized rna | 12 |
separate experiments | 12 |
messenger rna | 12 |
standard deviations | 12 |
purified mhv | 12 |
productive infection | 12 |
may explain | 12 |
particle formation | 12 |
complete genome | 12 |
leader rnas | 12 |
uv light | 12 |
macrophage cultures | 12 |
mrna mrna | 12 |
viral spike | 12 |
available data | 12 |
evolutionary relationship | 12 |
change values | 12 |
probably due | 12 |
peplomeric glycoprotein | 12 |
mrna capping | 12 |
mhv pathogenesis | 12 |
also significantly | 12 |
host cellular | 12 |
may differ | 12 |
antibodies specific | 12 |
died within | 12 |
many tissues | 12 |
six subgenomic | 12 |
remyelinated axons | 12 |
breeding populations | 12 |
mouse cytomegalovirus | 12 |
murine rotavirus | 12 |
different mouse | 12 |
statistical significance | 12 |
dmem supplemented | 12 |
fah ab | 12 |
drinking water | 12 |
also occur | 12 |
nidovirus helicases | 12 |
virus receptor | 12 |
host response | 12 |
high dose | 12 |
independent infection | 12 |
containing fetal | 12 |
lethal mhv | 12 |
secondary site | 12 |
zn site | 12 |
serological assays | 12 |
polypyrimidine tract | 12 |
signaling pathways | 12 |
cell clone | 12 |
euthymic mice | 12 |
two murine | 12 |
key role | 12 |
dna sequencing | 12 |
enteric infection | 12 |
described earlier | 12 |
recombinant ifn | 12 |
experimental viral | 12 |
glycoprotein ectodomain | 12 |
microglial cells | 12 |
investigated whether | 12 |
confers susceptibility | 12 |
macrophage infiltration | 12 |
direct viral | 12 |
receptor specificity | 12 |
frequently used | 12 |
dfmo treatment | 12 |
ibv strain | 12 |
acting element | 12 |
also suggest | 12 |
current studies | 12 |
species barrier | 12 |
transformed mouse | 12 |
ts phenotype | 12 |
contaminated biological | 12 |
nidovirus helicase | 12 |
gap junctions | 12 |
replicase polyproteins | 12 |
kg day | 12 |
interferon response | 12 |
lateral columns | 12 |
much lower | 12 |
cells also | 12 |
cells isolated | 12 |
cord grey | 11 |
pr infection | 11 |
organ cultures | 11 |
data also | 11 |
cl pro | 11 |
indicated time | 11 |
beta interferon | 11 |
conjugated goat | 11 |
expression patterns | 11 |
polypeptide encoded | 11 |
primary demyelination | 11 |
increased susceptibility | 11 |
stimulate class | 11 |
proinflammatory cytokines | 11 |
days prior | 11 |
pcr assay | 11 |
individual mice | 11 |
cell species | 11 |
mice deficient | 11 |
coronavirus endou | 11 |
expression profiles | 11 |
liver cells | 11 |
important roles | 11 |
lesions include | 11 |
rna extracted | 11 |
permissive macrophages | 11 |
esterase protein | 11 |
frameshift site | 11 |
heat shock | 11 |
infection compared | 11 |
acid identity | 11 |
sclerosis society | 11 |
continuous cell | 11 |
authors thank | 11 |
fusion proteins | 11 |
pattern recognition | 11 |
rous sarcoma | 11 |
different regions | 11 |
strain mice | 11 |
perinuclear region | 11 |
second open | 11 |
vec cells | 11 |
diagnosis diagnosis | 11 |
mouse antibody | 11 |
retrograde transport | 11 |
specific cytotoxic | 11 |
week old | 11 |
network analysis | 11 |
sequence data | 11 |
pathological changes | 11 |
ibv strains | 11 |
also involved | 11 |
cell periphery | 11 |
art cells | 11 |
replicative enzymes | 11 |
fully susceptible | 11 |
host protein | 11 |
common ancestor | 11 |
protective role | 11 |
cells present | 11 |
signs include | 11 |
infected controls | 11 |
putative proteases | 11 |
epizootic diarrhea | 11 |
long periods | 11 |
liver histology | 11 |
possible role | 11 |
bound mhv | 11 |
culture supernatants | 11 |
aug codon | 11 |
stem cell | 11 |
neuronal cells | 11 |
reads mapping | 11 |
following transplantation | 11 |
observations indicate | 11 |
fresh media | 11 |
disease due | 11 |
terminal signal | 11 |
persistent mhv | 11 |
develop chronic | 11 |
dmv formation | 11 |
mice compared | 11 |
predicted molecular | 11 |
expression changes | 11 |
luciferase reporter | 11 |
protease inhibitors | 11 |
expression may | 11 |
cell lysate | 11 |
coronaviruses isolated | 11 |
fatal diarrhea | 11 |
opportunistic infections | 11 |
based secondary | 11 |
virol doi | 11 |
early times | 11 |
nondenaturing page | 11 |
cc group | 11 |
sigma chemical | 11 |
viral lineages | 11 |
infectious cycle | 11 |
autoproteolytic cleavage | 11 |
examined whether | 11 |
molar excess | 11 |
increased resistance | 11 |
fah sequence | 11 |
conserved domain | 11 |
mammary tumors | 11 |
induced genes | 11 |
nt upstream | 11 |
colonic hyperplasia | 11 |
data shown | 11 |
group iii | 11 |
intestinal epithelial | 11 |
respiratory epithelium | 11 |
receptor expression | 11 |
using trizol | 11 |
chemokine ligand | 11 |
inhibited mhv | 11 |
main proteinase | 11 |
ctl escape | 11 |
enters cells | 11 |
neurotropic strain | 11 |
sev infection | 11 |
well established | 11 |
neural pathways | 11 |
days following | 11 |
recombinant ceacam | 11 |
lines confers | 11 |
mediated protection | 11 |
studies indicate | 11 |
wasting disease | 11 |
antibodies directed | 11 |
column buffer | 11 |
culture fluid | 11 |
another study | 11 |
yet known | 11 |
side chain | 11 |
mhv particles | 11 |
sequence divergence | 11 |
structural features | 11 |
trypan blue | 11 |
genetic marker | 11 |
tlr ligand | 11 |
rich region | 11 |
resistant strains | 11 |
may facilitate | 11 |
reduction factor | 11 |
viral gene | 11 |
small rna | 11 |
late endosomes | 11 |
chronic inflammatory | 11 |
oral route | 11 |
cov replicase | 11 |
persistent mouse | 11 |
substrate specificity | 11 |
recombinant strains | 11 |
hind limb | 11 |
mature virions | 11 |
viral strain | 11 |
kupffer cells | 11 |
viral transcription | 11 |
tumor cell | 11 |
cell interactions | 11 |
proteins nsp | 11 |
viral encephalitis | 11 |
flaccid paralysis | 11 |
major structural | 11 |
mosaic virus | 11 |
western europe | 11 |
least weeks | 11 |
culture dishes | 11 |
possible explanation | 11 |
ciency virus | 11 |
mutation rates | 11 |
adenovirus infection | 11 |
intergenic sequence | 11 |
may include | 11 |
also affect | 11 |
coronavirus isolates | 11 |
using specific | 11 |
primary cultures | 11 |
activity associated | 11 |
results presented | 11 |
clinical symptoms | 11 |
lung epithelial | 11 |
start sites | 11 |
reaction products | 11 |
clara cell | 11 |
apparent molecular | 11 |
golgi region | 11 |
structure prediction | 11 |
reaction mixture | 11 |
high degree | 11 |
cell mediated | 11 |
well conserved | 11 |
associated molecular | 11 |
studies will | 11 |
identified using | 11 |
proteolytic activity | 11 |
cells ml | 11 |
old balb | 11 |
egfp fluorescence | 11 |
temperate phage | 11 |
cholesterol supplementation | 11 |
among coronaviruses | 11 |
jhm polymerase | 11 |
nsp exoribonuclease | 11 |
natural transmission | 11 |
spike genes | 11 |
may participate | 11 |
stimulated genes | 11 |
egfp viruses | 11 |
clone plld | 11 |
arterivirus nsp | 11 |
viral attachment | 11 |
riboseq density | 11 |
conserved across | 11 |
within orf | 11 |
virus fusion | 11 |
transcription complex | 11 |
fold molar | 11 |
shifting signal | 11 |
subcellular localization | 11 |
regulated genes | 11 |
located within | 11 |
experimental studies | 11 |
neutralization test | 11 |
mhv titers | 11 |
single cell | 11 |
new england | 11 |
genome sequences | 11 |
mhv gene | 11 |
coronavirus papain | 11 |
viruses derived | 11 |
cells grown | 11 |
see text | 11 |
target tissues | 11 |
binding assay | 11 |
nucleocapsid proteins | 11 |
host genes | 11 |
evidence suggests | 11 |
pairing interactions | 11 |
replicative organelles | 11 |
dm strain | 11 |
infection causes | 11 |
mouse origin | 11 |
nasal epithelial | 11 |
also revealed | 11 |
encephalomyocarditis virus | 11 |
using anti | 11 |
heptad repeat | 11 |
coronavirus spread | 11 |
fully resistant | 11 |
mouse population | 11 |
ig site | 11 |
quantitative pcr | 10 |
comparative amino | 10 |
hemagglutinating encephalomyelitis | 10 |
constitutive exocytic | 10 |
cells showed | 10 |
common leader | 10 |
polyoma virus | 10 |
animal experiments | 10 |
blot competition | 10 |
intestinal epithelium | 10 |
isogenic recombinant | 10 |
host relationships | 10 |
specific mrnas | 10 |
comparative studies | 10 |
corona virus | 10 |
weakly neurotropic | 10 |
infected wt | 10 |
rna complex | 10 |
rna viral | 10 |
rabbit polyclonal | 10 |
ph dependence | 10 |
lipid composition | 10 |
binding properties | 10 |
markedly reduced | 10 |
intact cells | 10 |
oligonucleotide fingerprinting | 10 |
avian coronaviruses | 10 |
chronic stage | 10 |
fc receptor | 10 |
mobility group | 10 |
fgl prothrombinase | 10 |
pvm infection | 10 |
oxide synthase | 10 |
coronavirus contains | 10 |
novel murine | 10 |
antiviral defense | 10 |
nuclear magnetic | 10 |
host responses | 10 |
mediated remyelination | 10 |
group box | 10 |
derived ros | 10 |
ripa buffer | 10 |
von brunn | 10 |
polyprotein processing | 10 |
medium supplemented | 10 |
growth curves | 10 |
inflammatory cytokine | 10 |
environmental factors | 10 |
vast majority | 10 |
system infection | 10 |
virus glycoproteins | 10 |
expressing cells | 10 |
adpr antibody | 10 |
mammalian coronaviruses | 10 |
functional gene | 10 |
expression pattern | 10 |
chimeric mhv | 10 |
metal ions | 10 |
wt littermates | 10 |
mononuclear cell | 10 |
proteinase domains | 10 |
causes severe | 10 |
inflammatory lesions | 10 |
cov infections | 10 |
life strategy | 10 |
donor rna | 10 |
infection model | 10 |
also contain | 10 |
master mix | 10 |
protein folding | 10 |
pathogenic role | 10 |
virus mutants | 10 |
induced hepatitis | 10 |
eav nsp | 10 |
gene knockout | 10 |
disease may | 10 |
coronavirus species | 10 |
glycoprotein responsible | 10 |
chemical co | 10 |
translation initiation | 10 |
conserved rna | 10 |
human enteric | 10 |
budding compartment | 10 |
two papain | 10 |
delayed brain | 10 |
lesser extent | 10 |
brain tumor | 10 |
encoded proteins | 10 |
balb cke | 10 |
high concentrations | 10 |
results demonstrated | 10 |
replication sites | 10 |
nsp antibody | 10 |
different rna | 10 |
also induced | 10 |
binding ability | 10 |
reaction conditions | 10 |
el glycoprotein | 10 |
tris ph | 10 |
early studies | 10 |
equine encephalitis | 10 |
important determinant | 10 |
respiratory infection | 10 |
viral loads | 10 |
better understand | 10 |
macrophage cell | 10 |
wide range | 10 |
light microscopy | 10 |
humoral immunity | 10 |
previously identified | 10 |
significant reduction | 10 |
coronavirus structural | 10 |
complex class | 10 |
reflect differences | 10 |
rnaseq densities | 10 |
virus doses | 10 |
cultures infected | 10 |
peak titers | 10 |
mouse macrophages | 10 |
fh model | 10 |
rhinovirus infection | 10 |
related glycoprotein | 10 |
antiviral host | 10 |
excellent technical | 10 |
two domains | 10 |
brain infection | 10 |
reticulovesicular network | 10 |
protein mutants | 10 |
intraperitoneal injection | 10 |
polyethylene glycol | 10 |
crystal structures | 10 |
tmev infection | 10 |
dbt culture | 10 |
structural genes | 10 |
sequence requirement | 10 |
meningeal cultures | 10 |
nsp idl | 10 |
coronavirus hemagglutinin | 10 |
olfactory nerve | 10 |
genetic basis | 10 |
chemokine expression | 10 |
gene sequences | 10 |
virus produce | 10 |
pseudoknot structure | 10 |
activity may | 10 |
luciferase activities | 10 |
primary olfactory | 10 |
day prior | 10 |
persistent virus | 10 |
ig sequence | 10 |
protein forms | 10 |
base pair | 10 |
virus activity | 10 |
among mouse | 10 |
cov genome | 10 |
poliovirus rna | 10 |
marker genes | 10 |
biological processes | 10 |
recent work | 10 |
cell sections | 10 |
bacterial infection | 10 |
baby hamster | 10 |
epitope spreading | 10 |
might also | 10 |
coronavirus receptor | 10 |
cell effector | 10 |
replicative intermediate | 10 |
viral model | 10 |
virus dose | 10 |
cold pbs | 10 |
secondary lymphoid | 10 |
liver cell | 10 |
hsp family | 10 |
small membrane | 10 |
cytoplasmic lysates | 10 |
optical density | 10 |
serological monitoring | 10 |
murine adenovirus | 10 |
intranasal infection | 10 |
target organs | 10 |
many viruses | 10 |
viral pathogens | 10 |
coronavirus vaccines | 10 |
experimental models | 10 |
foreign gene | 10 |
map testing | 10 |
infection triggers | 10 |
asymptomatic infection | 10 |
two rna | 10 |
might play | 10 |
neutralizing activity | 10 |
following exposure | 10 |
studies suggested | 10 |
immune evasion | 10 |
mixed infection | 10 |
petri dishes | 10 |
highly deg | 10 |
neutralizing monoclonal | 10 |
guanine nucleotide | 10 |
murine model | 10 |
clinically apparent | 10 |
thymus involution | 10 |
purified recombinant | 10 |
recipient mice | 10 |
eagle medium | 10 |
independent assembly | 10 |
inoculated i | 10 |
treated animals | 10 |
mediated enhancement | 10 |
demyelinating plaques | 10 |
bf sha | 10 |
tissue injury | 10 |
experimental model | 10 |
encoding region | 10 |
parental strain | 10 |
molecular interactions | 10 |
chronic liver | 10 |
resistant mouse | 10 |
relatively small | 10 |
glycyrrhetinic acid | 10 |